Jesse Papenburg

Has grant

Associate Professor

McGill University

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jesse Papenburg is an Associate Professor at McGill University in Canada. His research focuses on antibiotic synergy against Staphylococcus aureus, the prevention of respiratory syncytial virus, and the implementation of Telehealth antimicrobial stewardship programs. He has published several articles addressing critical issues in pediatric infectious diseases and immunization strategies.

Recent Grants

Grant: Open

Staphylococcus aureus Network Adaptive Platform trial in Pediatrics and Youth (SNAP-PY), Canada

Open Date: 2024-09-01

Close Date: 2028-08-01

Grant: Close

Infections virales respiratoires sévères chez l'enfant: épidémiologie et optimisation de l'utilisation des outils diagnostics

Open Date: 2016-04-01

Close Date: 2019-03-31

Grant: Close

Infections virales respiratoires sévères chez l’enfant: épidémiologie et optimisation de l’utilisation des outils diagnostics

Open Date: 2016-04-01

Close Date: 2021-03-31

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

Simon B. Drysdale

University College London

UNITED KINGDOM

View details

Alexander Lawandi

Assistant Professor

McGill University Health Centre

CANADA

View details

James Nokes

Professor

University of Warwick

UNITED KINGDOM

View details

Rosa Rodriguez Fernandez

Profesor asociado de Pediatria

Universidad Complutense de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jesse Papenburg

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

The combinations of cefazolin with linezolid and cefazolin with clindamycin are indifferent against methicillin-susceptible Staphylococcus aureus

Antibiotic synergy against Staphylococcus aureus : a systematic review and meta-analysis

Use of the moving epidemic method to guide the launch of palivizumab immunization campaigns for respiratory syncytial virus in Québec, Canada

The Critical Lens: It is time to start using the right test for febrile young infants

Prioritising respiratory syncytial virus prevention in low-income and middle-income countries.

The effect of Telehealth Antimicrobial Stewardship Program (Tele-ASP) on antimicrobial use in a pediatric intensive care unit: Pre- and post-implementation single center study

Les infections à paréchovirus chez les nourrissons.

Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.

Outcomes of immunocompromised children hospitalized for influenza, 2010-2021, the Canadian Immunization Monitoring program active (IMPACT).

Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data.

Collaborators (4)

Simon B. Drysdale

Alexander Lawandi

James Nokes

Rosa Rodriguez Fernandez

Make your next move.